(Total Views: 822)
Posted On: 01/31/2022 2:37:03 PM
Post# of 157591
Re: craigakess #116937
Merger is never smooth transition from what I’ve read. We can’t forget GILD was thinking of merging with IMMU before they decided to buy it out. Don’t forget the CEO of that company was let go and a short time after they were purchased by GILD. Shocker…
Not having a new CEO could mean once the Ink drys we get the CEO.
Not having a new CEO could mean once the Ink drys we get the CEO.
(2)
(0)
Daniel Rizzo
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf
Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf
